Page 24 - கிளின்டன் ஆரோக்கியம் நுழைவு முயற்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

F. Hoffmann-La Roche Ltd Roche’s awarded WHO prequalification for the HIV and HCV diagnostic tests on the cobas 6800/8800 Systems Roche’s awarded WHO prequalification for the HIV and HCV diagnostic tests on the cobas 6800/8800 Systems For patients living in areas with limited healthcare resources, WHO prequalification ensures access to the highest quality diagnostics Access to broader reliable diagnostic solutions helps healthcare communities working to expedite and increase disease elimination programs Roche’s Global Access Program provides innovative diagnostic solutions improving disease and patient management for those most in need Basel, 11 March 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the cobas® HIV-1 and cobas® HCV Tests for use on the cobas® 6800/8800 Systems have been awarded World Health Organization (WHO) prequalification. WHO prequalification helps regulators and procurers in low and middle-income countries to identify products that

United statesNathalie meetzDaniel grotzkyThomas schineckerPatrick barthKarsten kleineClinton health access initiativeWorld health organizationRoche global access programGlobal fundRoche groupPharmaceuticals industryRoche group media relationsGlobal access programPlasma separation cardGlobal access